MIS Sacroiliac Joint Fusion Market Size, Share and Industry Analysis By Type (Open Surgery of Sacroiliac Joint Fusion and Minimally Invasive Surgery) By Application (ASC and Hospitals), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

MIS SACROILIAC JOINT FUSION MARKET REPORT OVERVIEW

The global mis sacroiliac joint fusion market was valued at USD 0.31 billion in 2024 and is expected to grow to USD 0.36 billion in 2025, reaching USD 1.21 billion by 2033, with a projected CAGR of 16.3% from 2025 to 2033.

Minimally invasive surgery (MIS) sacroiliac joint fusion is a surgical process that is responsible for the fusion of the iliac bone (pelvis) with the spinal. A sacroiliac joint is a joint in the pelvis that is held by several ligaments in the human body. It is a surgical process carried out to cure joint pains, spinal instability, cancers, trauma, infection, and others. It can be performed in a minimally invasive manner or an open surgery of sacroiliac joints. It improves recovery time and cures patients effectively. The demand for advanced joint treatment is increasing rapidly. The MIS sacroiliac joint fusion treatment helps repair the joint and improves its ability to absorb shocks for the spinal cord. 

The demand for advanced surgical procedures and medical treatment is increasing rapidly because of the prevalence of joint and spinal problems among the population. It effectively cures cord problems and improves the functionality of the patients. Increased spending on advanced healthcare procedures is expected to fuel the demand for joint fusion surgery. In addition, the rising demand for minimally invasive surgeries may boost the growth of the MIS sacroiliac joint fusion market.

MIS SACROILIAC JOINT FUSION MARKET KEY FINDINGS

• Market Size and Growth: Over 12 978 SI joint fusion procedures were performed in the most recent reporting period, 76.5 % of which were MIS approaches.

• Key Market Driver: 81.4 % of MIS SI fusion patients (N = 102) met composite success criteria at 6 months post surgery.

• Major Market Restraint: Coverage prerequisites include at least one diagnostic block (≥ 75 % pain relief), one therapeutic injection (≥ 50 % relief), and both CT and MRI imaging (minimum 4 interventions).

• Emerging Trends: Introduction of Category III CPT® codes for intra articular MIS fusion (effective January 1, 2023) and hybrid procedures (effective July 1, 2023).

• Regional Leadership: SI BONE’s iFuse System reached over 65 000 procedures worldwide, with more than 7 000 U.S. cases annually as of January 2022.

• Competitive Landscape: Two primary CPT® codes (27279 and 27278) drive the U.S. MIS SI fusion market.

• Market Segmentation: MIS techniques comprised 76.5 % of the 12 978 SI joint fusion procedures in the latest period.

• Recent Development: CMS implemented Local Coverage Determination L39810 for minimally invasive SI joint arthrodesis effective April 17, 2025.

COVID-19 IMPACT

Increasing Cases of Health Problems to Fuel Demand for Advanced Healthcare Procedures

The COVID-19 pandemic has negatively affected several markets worldwide. The demand for advanced healthcare procedures is expected to increase the adoption of the product rapidly. The demand for advanced healthcare procedures is increasing rapidly because of the prevalence of several spinal problems. Its rising demand from the healthcare sector is expected to improve demand and allow manufacturers to produce advanced processes. Governments invest heavily in the development of advanced healthcare procedures such as MIS sacroiliac joint fusion because of its ability to cure disorders efficiently. The production activities of healthcare equipment are increasing rapidly because of the demand for healthcare equipment and medical gear. The use of technologically advanced production machinery has empowered manufacturers to reduce labor costs and recover costs. MIS joint infusion is an effective tool that effectively cures joint problems. Therefore, these factors are estimated to propel the market growth during the pandemic.  

LATEST TRENDS

Rising Demand for Minimally Invasive Procedures to Facilitate Industry Growth

The adoption of MIS sacroiliac joint fusion is increasing rapidly because of the rising demand for minimally invasive surgical procedures. The rising cases of joint problems such as arthritis among the elderly population are responsible for the industry growth. As per the information provided by the National Health Portal of India, the frequency of osteoarthritis is the most common disorder among women of 65 years and above. Minimally invasive procedures are used because of their high recovery rate. The geriatric population is unable to recover effectively from open surgeries, which, in turn, boosts the demand for minimally invasive sacroiliac fusion surgeries. Improper posture, bumps, excessive driving, and inactive lifestyle lead to the prevalence of spinal injuries. The adoption of sacroiliac fusion efficiently eliminates problems related to bone marrow. It is a procedure that efficiently eliminates disorders from bone and enables patients to recover fast. 

It is used to cure bone marrow disorders because of its ability to reduce pains and enhance recovery time. Evolving health preferences and increased spending capacity on advanced medical procedures are responsible for the growth of the MIS sacroiliac joint fusion market. 

• According to a National Institutes of Health–funded study, 12 978 sacroiliac joint fusion procedures were performed in the latest reporting period, with 76.5 % conducted via minimally invasive surgical (MIS) approaches.

• According to the American Medical Association, a Category III CPT® code for intra‑articular MIS SI joint fusion became effective January 1, 2023, and a second “hybrid” code for combined lateral‑transfixing and intra‑articular implants became effective July 1, 2023.

Request a Free sample to learn more about this report

MIS SACROILIAC JOINT FUSION MARKET SEGMENTATION

By Type

By type, the market is classified into Open Surgery and Minimally Invasive Surgery. 

The minimally invasive segment is expected to soar because of the strong demand for treatment procedures that facilitate fast recovery. The minimally invasive surgical procedures provide excellent accuracy and precision and allow surgeons to perform tasks effectively. The improvement in material quality and effectiveness of the procedures provokes manufacturers to produce medical instruments and devices in bulk. Therefore, these factors may aid the market's growth. 

By Application

Based on application, the market is categorized into ASC and Hospitals. 

The ambulatory surgical centers (ASC) segment is expected to lead the market because of the convenience and speed of surgery. The procedures do not require admission and are performed on the visiting day. It is an effective procedure that is extensively used by several patients because of the speed and recovery time. Hectic schedules of the patients fuel the growth of the surgical centers, thereby promoting industry growth. 

DRIVING FACTORS

Prevalence of Lower Back Pain to Foster Industry Growth

MIS sacroiliac joint fusion is used extensively to cure several problems associated with the spinal cord. The surgical procedure increases the recovery rate and cures the body effectively. The increasing cases of lower back pain and adoption are attributable to improper sitting and sleeping posture and desk-bound jobs. This factor increases healthcare's adoption. It is an extremely safe and reliable procedure that effectively cures patients with minimal incision. It enhances the joint's strength and allows the body to improve joint strength between limbs. It fastens patient recovery and successfully eliminates the disorder in an effective manner. SI-BONE offers a sacroiliac fusion procedure named iFuse that allows surgeons to accurately reach joints and fix the damage in specific areas. It is an extremely precise and effective method for curing joint problems. 

Increased Spending on Advanced Healthcare Device and Treatment Procedures to Fuel Industry Growth

The evolving lifestyle of consumers and the technological advancement in medical science have led to the development of advanced implant technologies. It uses several devices to insert repairing agents that enhance joint strength. Heavy government investments in healthcare infrastructure have led to the adoption of advanced medical processes. It is an extremely effective healthcare tool that cures several complex joint pain problems. Manufacturers aim to use advanced materials that minimize incisions and boost the precision of the surgical instrument to improve effectiveness. As per the information provided by the National Library of Medicine, the rate of open surgery touches approximately 20%-90% and 13%-100% for MIS surgery. It is used extensively to cure joint pains because of the procedure's effectiveness. The production of joint fusion devices is increasing rapidly because of their demand from medical professionals. These factors would drive the MIS sacroiliac joint fusion market growth.

• According to North American Spine Society coverage recommendations, 81.4 % of patients (N = 102) achieved composite success at 6 months post‑MIS SI joint fusion—defined by pain reduction, absence of serious adverse events or neurological worsening, and no repeat surgery.

• According to the Centers for Medicare & Medicaid Services, coverage criteria mandate ≥ 75 % pain reduction from one diagnostic SI joint block and ≥ 50 % from one therapeutic intra‑articular injection before MIS fusion is approved.

RESTRAINING FACTORS

Lack of Awareness Regarding the Benefits of the Treatment Procedure to Hinder Market Growth

The lack of awareness regarding the benefits of the minimally invasive surgical process acts as a major restraining factor for the industry. This results in the adoption of alternative options such as anti-inflammatory drugs and open surgery. Concerns regarding the effectiveness and reliability of MIS sacroiliac fusion surgery hamper its adoption radically. Therefore, these factors are expected to hamper the growth of the market. 

• According to CMS Local Coverage Determination L39810, patients must undergo a minimum of four preoperative interventions—one diagnostic block, one therapeutic injection, CT and MRI imaging—before becoming eligible for MIS SI fusion coverage

• According to a CMS coding article (A59961), device migration occurred in 1 out of 50 MIS SI fusion implants (2 %), necessitating additional stabilization

• Request a Free sample to learn more about this report

•  

MIS SACROILIAC JOINT FUSION MARKET REGIONAL INSIGHTS

Presence of Developed Healthcare Infrastructure to Boost Market Growth in North America

North America is expected to dominate the MIS sacroiliac joint fusion market share because of the development of infrastructure facilities in the U.S. Technological advancements in healthcare and abundance of raw materials allow manufacturers to set up their facilities in major cities of the region. Furthermore, evolving lifestyle and rising infrastructure facilities lead to the MIS sacroiliac joint fusion surgical procedure's adoption. Government backing for the citizen's health leads to the development of easily accessible surgical facilities and hospitals that utilize the technology. These factors are estimated to propel market growth. 

Europe is expected to be the second-largest shareholder because of the availability of advanced healthcare facilities. Rapidly developing infrastructure facilities and increasing demand for advanced healthcare facilities shall boost the MIS sacroiliac joint fusion surgical procedure's implementation. Increased healthcare expenditure and rapid development are estimated to boost the MIS sacroiliac joint fusion market development. 

In Asia Pacific, rapid urbanization and increasing demand for advanced healthcare services shall boost the demand for implant technologies. Rapid technological advancements in healthcare technology in developing and developed countries such as India and China are estimated to develop the market. In countries such as India, lower treatment facilities and government subsidies lead to the adoption of advanced facilities. 

In Latin America and the Middle East & Africa, increasing purchasing power and improving lifestyle are likely to propel the demand for minimally invasive surgical procedures. This factor is expected to bolster market growth. 

KEY INDUSTRY PLAYERS

Strategies Devised by Key Players Increase Implementation of MIS to Help Players to Grow

Prominent companies operating in the market invest heavily in research and development to enhance the quality of MIS devices to increase efficiency. The adoption of better laser components and stronger materials enable medical professionals to successfully undertake surgeries and solve disorders effectively. This strategy empowers companies to improve their sales drastically and improve annual revenues.

• SI‑BONE: According to SI‑BONE reporting, its iFuse® Implant System was used in over 65 000 procedures worldwide as of January 2022, including more than 7 000 in the U.S. annually

• Medtronic: According to Medtronic, surgeons typically place two Rialto™ SI fusion devices per MIS procedure to achieve optimal joint stabilization

The adoption of expansion strategies enables manufacturers to set up manufacturing facilities in several regions and satisfy the demand for advanced healthcare services. This strategy can expand their market reach considerably. Further, the adoption of technologically advanced production techniques improves their production quality, improves efficiency, reduces labor cost and resource consumption, boosts the production capacity of healthcare devices, and achieves set goals. This strategy shall enable them to achieve a remarkable market position. 

List of Top MIS Sacroiliac Joint Fusion Companies

• SI-BONE
• Medtronic
• Zimmer Biomet
• Orthofix
• Zyga Technology
• Xtant Medical
• Globus Medical
• Life Spine
• CoreLink
• VGI Medical
• SIGNUS Medizintechnik

INDUSTRY DEVELOPMENT

March 2021- Aurora Spine Corporation a manufacturer of medical devices launched a proprietary minimally invasive surgical system named SiLO™ Posterior SI Joint Fusion System. It is specifically made for posterior sacroiliac fusion surgical procedures. 

REPORT COVERAGE

This report highlights the leading segments and the recent market trends. It comprehensively discusses the impact of COVID-19 and the driving and restraining factors. Observes strategies deployed by the major key players and the regional developments. Informs readers about the various business decisions undertaken by companies that help them grow.